title: Eight more ways to deal with antibiotic resistance.
abstract: The fight against antibiotic resistance must be strengthened. We propose actions that U.S. government agencies and private sector entities can take to build a more comprehensive effort. These actions can increase the viability of investing in new antibiotics, ensure the quality and stewardship of all antibiotics, and make responses to emerging resistance more informed. Success requires the thoughtful exercise of federal authority and a firm commitment to share data and reward developers for the value generated with new, life-saving antibiotics.
authors.affiliation: U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Broad Spectrum Antimicrobials Program, Washington, DC, USA matt.metz@pioneer.com.
authors.forename: Matthew
authors.initials: M
authors.lastname: Metz
authors.affiliation: Anti-Infectives Consulting LLC, Stonington, Connecticut, USA.
authors.forename: David M
authors.initials: DM
authors.lastname: Shlaes
mesh_terms: D000822:Animal Husbandry / Q000331:legislation & jurisprudence*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D033181:Information Dissemination / Q000941:ethics; D017149:Private Sector / Q000331:legislation & jurisprudence; D011786:Quality Control; D014481:United States; D037041:United States Government Agencies / Q000331:legislation & jurisprudence*
chemical_list: D000900:Anti-Bacterial Agents